Beckman Coulter Laboratory Systems (suzhou) Co., Ltd. recalls DxC 500 AU Clinical Chemistry Analyzer
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Beckman Coulter has identified an issue which prevents the DxC 500 AU instrument from providing the correct onboard stability (Open Expiration) dates for assays that were loaded prior to a software upgrade (e.g. 1.3 to 1.4, 1.4 to 1.4.1, etc.). As a result, assays that have expired may still be used for sample processing, leading to inaccurate or erroneous patient test results. The issue only happens on assays loaded before instruments doing upgrades and does not impact new installation. It does not impact the assays loaded after upgrade.
- Products
-
- DxC 500 AU Clinical Chemistry Analyzer
- Company
- Beckman Coulter Laboratory Systems (suzhou) Co., Ltd.
- Where it was sold
-
US: MA, CA, SC, LA, OK, GA, AL, TX, OR, ID, CO, MN, NY, MS, PA, WA, IL, MI, PR. OUS: Lebanon, Poland, Ghana, Spain, South Africa, Slovakia, Ghana, Croatia, Seychelles, Australia, Republic of Korea
States: Alabama, California, Colorado, Georgia, Idaho, Illinois, Louisiana, Massachusetts, Michigan, Minnesota, Mississippi, New York, Oklahoma, Oregon, Pennsylvania, Puerto Rico, South Carolina, Texas, Washington
- Units affected
- 56
- About this recall
- DxC 500 AU Clinical Chemistry Analyzer, REF: C63519, and C63520 with affected software.